Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vitamin E × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 10 Gastrointestinal 5 Breast 5 Thoracic 3 Tumor-Agnostic 2 Other neoplasm 2 Lymphoid 2 Head & Neck 2 Other hematologic neoplasm 1 Other 1 Myeloid 1 Gynecologic 1 Dermatologic 1 Classical hematology 1 CNS 1

Conditions

Non-melanoma Skin Cancer 1

Interventions

pembrolizumab 290 Nivolumab 258 Ipilimumab 231 Cyclophosphamide 169 aldesleukin 130 Interleukin-2 93 fludarabine phosphate 88 trametinib 78 fludarabine 72 dabrafenib 68 Radiotherapy 67 Dacarbazine 66 Temozolomide 65 Biopsy 63 Vemurafenib 61 Imiquimod 48 Radiosurgery 47 Bevacizumab 46 Magnetic Resonance Spectroscopy 44 sargramostim 43 Blood Specimen Collection 42 Specimen Handling 41 Aminolevulinic Acid 41 Peripheral Blood Stem Cell Transplantation 40 3-ingenyl angelate 40 Cisplatin 39 cemiplimab 38 Paclitaxel 38 atezolizumab 36 Carboplatin 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00392561 2023-04-26

BEST

University of Chicago

Phase NA Completed

Non-melanoma Skin Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡